Last update 08 May 2025

Intravenous citrulline

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Respiratory DiseasesOther DiseasesCongenital Disorders+ [1]
Active Indication
Acute Lung InjuryVaso-occlusive crisis
Inactive Indication-
Originator Organization
Asklepion Pharmaceuticals LLCAsklepion Pharmaceuticals LLC
Active Organization
Asklepion Pharmaceuticals LLCAsklepion Pharmaceuticals LLC
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with Intravenous citrulline
IRCT20221128056642N1
/ SuspendedPhase 2/3IIT
The Effect of Acute and Chronic L-Citrulline and Citrulline Malate Supplementation on Resistance Training Performance, Muscle Soreness, Lactate and Nitric Oxide in Resistance-Trained Men
ISRCTN11694009
/ CompletedNot ApplicableIIT
Effect of isolated and combined ingestion of caffeine and citrulline malate on resistance exercise and jumping performance: a randomized double-blind placebo-controlled crossover study
IRCT20190915044772N1
/ CompletedPhase 3IIT
The Effects of Short Term Citrulline malate Supplementation on Oxidative Stress Markers and Muscle damage of Trained Soccer Players
100 Clinical Results associated with Intravenous citrulline
Login to view more data
100 Translational Medicine associated with Intravenous citrulline
Login to view more data
100 Patents (Medical) associated with Intravenous citrulline
Login to view more data
100 Deals associated with Intravenous citrulline
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lung InjuryPhase 3
United States
Asklepion Pharmaceuticals LLCAsklepion Pharmaceuticals LLC
07 Apr 2022
Vaso-occlusive crisisPhase 1
United States
Asklepion Pharmaceuticals LLCAsklepion Pharmaceuticals LLC
07 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT02697240 (CTgov)
Phase 1
Vaso-occlusive crisis | Acute Chest Syndrome
4
dywgvyrych(jrwvknjooy) = snxcvxdtjv egycgbqjys (thwwjwuhqa, llxjufapmr - sqoqxvxfgp)
View more
-
17 Apr 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free